Global Ocular Drug Delivery Market 2017: Focus on Novel Aerosol & Eye Drop Devices / Topical Delivery Technologies / Punctal Plugs / Injectables & Implants / Ocular Inserts / Drug Eluting Lenses

DUBLIN, August 31, 2017 /PRNewswire/ --

The "Ocular Drug Delivery: Market Overview, Delivery Technologies, and Partnering Opportunities" report has been added to Research and Markets' offering.

This report provides a comprehensive overview of the ocular drug delivery segment and includes detailed product and technology information, market data, DDS pipelines by therapeutic category, company profiles, and partnering opportunities.

It is an exciting time in the field of ocular drug delivery, with a number of innovative delivery systems showing promise. The market is currently dominated by topical products such as drops and ointments which are inefficient and can be difficult tadminister properly. Injectable formulations are available ta lesser extent and can be associated with serious side effects and require administration by a medical professional.

Fortunately there are a record number of companies developing improved ocular delivery systems which provide benefits such as sustained release, accurate dosing, and ease of administration. These companies range from emerging start-ups with preclinical projects testablished specialty companies with late-stage pipeline products.

Collectively, these companies have more than 70 novel ocular formulations and products in various stages of development for indications such as glaucoma, uveitis, macular degeneration, and dry eye disease.

Report Contents:

• Eye Diseases
• Overview and prevalence data
• Marketed therapeutics by indication
• Age-related macular degeneration
• Macular edema
• Diabetic retinopathy
• Glaucoma

• Ophthalmic Market Overview
• Sales of top ten ophthalmic products, 2015-2016
• Key players by revenue
• Key players with drug delivery-enabled products

• Ocular Drug Delivery Landscape
• Non-invasive and invasive delivery technologies
• Approved ocular drug delivery formulations
• Ocular drug delivery pipeline by therapeutic category
• Future perspectives and development opportunities

• 46 Company Profiles by Technology Type
• Novel aerosol and eye drop devices
• Punctal plugs
• Topical delivery systems
• Injectables and implants
• Ocular inserts
• Drug-eluting lenses

For each company profiled, the following information is provided:

• Technology Description
• Development Status / Pipeline Products
• Patents and Publications
• Partnership Opportunities
• Business Development & Licensing Contact

Sample of Companies Profiled:

• Aciont
• Envisia Therapeutics
• EyeGate Pharma
• Graybug Vision
• iVeena
• Kala Pharmaceuticals
• KMG Pharma
• Leo Lens Technology
• Mati Therapeutics
• Ocular Therapeutix
• Oculis Pharma
• pSivida
• Spindrift Therapeutics
• ViSci, Ltd.

Reasons to Buy:

• Identify enabling delivery systems or devices for pipeline drugs
• Scout technologies for life cycle management of commercialized ophthalmic drugs
• Understand the key players and therapeutic segments
• Obtain product and technology information for launched ophthalmics
• View pipeline details for novel ocular formulations in development
• Discover product and technology licensing opportunities

Key Topics Covered:

Chapter I: Eye Diseases

• Age Related Macular Degeneration (AMD)
• Macular Edema and Diabetic Retinopathy
• Glaucoma
• Inflammatory Conditions

Chapter II: Market Overview

• Key Players

Chapter III: Ophthalmic Drug Delivery Landscape

• Non-Invasive Delivery Technologies
• Invasive Delivery Technologies
• Approved Ocular DDS Products
• Ocular DDS Pipeline
• Development Opportunities
• Future Perspectives

Chapter IV: Technology Profiles

• Novel Aerosol & Eye Drop Devices
• CIS Pharma
• Eyenovia, Inc
• Mystic Pharmaceuticals, Inc
• Nemera
• SpinDrift Therapeutics
• Punctal Plugs
• Mati Therapeutics, Inc
• Ocular Therapeutix., Inc
• Topical Delivery Technologies
• Aciont, Inc
• Amorphex Therapeutics, Inc
• Apidel SA
• EyeCRO, LLC
• EyeGate Pharma
• EyeTrans Technologies, Inc
• InSite Vision, Inc
• Integral Ophthalmics, LLC
• Kala Pharmaceuticals, Inc
• Nanomerics
• Novaliq GmbH
• Oculis Pharma
• Santen SAS
• Seagull Technologies Pty Ltd
• Injectables & Implants
• AsclepiX Therapeutics, LLC
• Clearside Biomedical, Inc
• DelSiTech, Ltd
• Envisia Therapeutics, Inc
• Glaukos Corporation
• Graybug Vision, Inc
• Icon Bioscience, Inc
• iVeena Delivery Systems
• KMG Pharma, LLC
• Layer Bio, Inc
• Midatech Pharma, PlC
• Neurotech Pharmaceuticals, Inc
• Ocuject, LLC
• Ohr Pharmaceutical, Inc
• Peregrine Ophthalmic Pte Ltd
• PolyActiva Pty Ltd
• pSivida Corporation
• Replenish, Inc
• Spinnaker Biosciences, Inc
• Taiwan Liposome Company Limited
• TheraKine, Ltd
• Ocular Inserts
• Allergan plc
• ViSci Ltd. Visual Sciences
• Drug Eluting Lenses
• Leo Lens Technology, Inc
• OcuMedic, Inc
  

For more information about this report visit https://www.researchandmarkets.com/research/nx5dcm/ocular_drug

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com